Apotex Bid To Overturn Prilosec Decision Denied

Law360, New York (September 17, 2007, 12:00 AM EDT) -- A District of Columbia judge has refused to overturn a federal agency decision that blocked drug manufacturer Apotex Corp. from marketing a generic version of gastric-acid-inhibiting drug Prilosec because it infringed on Astrazeneca AB patents.

U.S. District Judge Ricardo M. Urbina ruled on Monday that Apotex had failed to show that it would likely win its case against the U.S. Food and Drug Administration and denied the generic drug maker's request for a preliminary injunction or restraining order against the federal agency.

Following a ruling by...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.